← All trials
NCT05281107
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 10, 2015
- Primary completion
- Sep 26, 2016
- Completion date
- Oct 1, 2016
- First posted
- Mar 16, 2022
- Last posted
- Mar 16, 2022
- Enrollment
- 106
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- International Medical University, Kuala LumpurLead sponsor
- International Medical University, Kuala LumpurReponsible party - principal investigator
- International Medical University, Kuala LumpurStudy chair
- International Medical University, Kuala LumpurStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.